Top Markets
Coin of the day
Lucira Health, Inc. Lucira Health, Inc.

Lucira Health, Inc.

LHDX
株式のランク #33751
Lucira Health, Inc. is a medical technology enterprise dedicated to the... Lucira Health, Inc. is a medical technology enterprise dedicated to the development and commercialization of diagnostic test kits for infectious diseases. The company has innovated a platform capable of providing molecular testing capabilities. Among its current product offerings is the LUCIRA COVID-19 All-In-One Test Kit, and it is also progressing with the development of diagnostic solutions for influenza A and B viruses. Lucira Health holds a patent license agreement with Eiken Chemical Co., Ltd., alongside technical and manufacturing service agreements with Jabil, Inc. and Jabil MSA, respectively. Founded in 2013, the company operated as DiAssess Inc. until January 2020 when it rebranded to Lucira Health, Inc. Its main offices are situated in Emeryville, California.
株価
$0.4523
最終同期: 2023-03-03
時価総額
$6.97M
変化(1日)
-19.23%
変化(1年)
0.00%
US
取引 Lucira Health, Inc. (LHDX)

カテゴリー

Lucira Health, Inc.(LHDX)の配当利回りの履歴
Lucira Health, Inc.(銘柄コード: LHDX)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Lucira Health, Inc.(LHDX)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)